The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour size

The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour size

Bibliographic Details
Main Authors: Jan Booij, Suat Simsek, Tessel M Boertien, Madeleine L Drent, Marcel P M Stokkel, Jantien Hoogmoed, Alberto Pereira, Nienke R Biermasz, Ronald Groote Veldman, Eric Fliers, Peter H Bisschop
Format: Article
Language:English
Published: BMJ Publishing Group 2020-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/8/e038250.full
id doaj-8ff8504fee624ff2acc29759bcbd5e02
record_format Article
spelling doaj-8ff8504fee624ff2acc29759bcbd5e022021-05-28T12:33:18ZengBMJ Publishing GroupBMJ Open2044-60552020-08-0110810.1136/bmjopen-2020-038250The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour sizeJan Booij0Suat Simsek1Tessel M Boertien2Madeleine L Drent3Marcel P M Stokkel4Jantien Hoogmoed5Alberto Pereira6Nienke R Biermasz7Ronald Groote Veldman8Eric Fliers9Peter H Bisschop104 Department of Radiology and Nuclear Medicine, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands 8 Internal Medicine, North West Hospital Group, Alkmaar, Noord-Holland, The Netherlands Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The NetherlandsDepartment of Internal Medicine, Section of Endocrinology, Amsterdam UMC, location VUMC, VU University, Amsterdam, The NetherlandsDepartment of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The NetherlandsDepartment of Neurosurgery, Neurosurgical Centre Amsterdam, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The NetherlandsDepartment of Medicine, Division of Endocrinology, and Centre for Endocrine Tumors Leiden (CETL), Leiden University Medical Centre, Leiden, The NetherlandsDepartment of Medicine, Division of Endocrinology, and Centre for Endocrine Tumors Leiden (CETL), Leiden University Medical Centre, Leiden, The NetherlandsDepartment of Internal Medicine, Medical Spectrum Twente, Enschede, The NetherlandsDepartment of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The NetherlandsDepartment of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlandshttps://bmjopen.bmj.com/content/10/8/e038250.full
collection DOAJ
language English
format Article
sources DOAJ
author Jan Booij
Suat Simsek
Tessel M Boertien
Madeleine L Drent
Marcel P M Stokkel
Jantien Hoogmoed
Alberto Pereira
Nienke R Biermasz
Ronald Groote Veldman
Eric Fliers
Peter H Bisschop
spellingShingle Jan Booij
Suat Simsek
Tessel M Boertien
Madeleine L Drent
Marcel P M Stokkel
Jantien Hoogmoed
Alberto Pereira
Nienke R Biermasz
Ronald Groote Veldman
Eric Fliers
Peter H Bisschop
The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour size
BMJ Open
author_facet Jan Booij
Suat Simsek
Tessel M Boertien
Madeleine L Drent
Marcel P M Stokkel
Jantien Hoogmoed
Alberto Pereira
Nienke R Biermasz
Ronald Groote Veldman
Eric Fliers
Peter H Bisschop
author_sort Jan Booij
title The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour size
title_short The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour size
title_full The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour size
title_fullStr The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour size
title_full_unstemmed The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour size
title_sort galant trial: study protocol of a randomised placebo-controlled trial in patients with a 68ga-dotatate pet-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour size
publisher BMJ Publishing Group
series BMJ Open
issn 2044-6055
publishDate 2020-08-01
url https://bmjopen.bmj.com/content/10/8/e038250.full
work_keys_str_mv AT janbooij thegalanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT suatsimsek thegalanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT tesselmboertien thegalanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT madeleineldrent thegalanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT marcelpmstokkel thegalanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT jantienhoogmoed thegalanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT albertopereira thegalanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT nienkerbiermasz thegalanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT ronaldgrooteveldman thegalanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT ericfliers thegalanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT peterhbisschop thegalanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT janbooij galanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT suatsimsek galanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT tesselmboertien galanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT madeleineldrent galanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT marcelpmstokkel galanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT jantienhoogmoed galanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT albertopereira galanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT nienkerbiermasz galanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT ronaldgrooteveldman galanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT ericfliers galanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
AT peterhbisschop galanttrialstudyprotocolofarandomisedplacebocontrolledtrialinpatientswitha68gadotatatepetpositiveclinicallynonfunctioningpituitarymacroadenomaontheeffectoflanreotideontumoursize
_version_ 1721424122565623808

Similar Items